Liver News and Research

RSS

Study explores role of APOBEC-mediated RNA editing in SARS-CoV-2 fitness

A new study investigated whether APOBEC proteins can directly edit the RNA sequence of SARS-CoV-2 to generate C-to-U mutations.

14 Apr 2022

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Researchers reviewed non-viral nano-vectors used for delivering the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated genome editing system.

14 Apr 2022

UCL researchers boost the effectiveness of therapeutic vaccine for chronic HBV

Scientists at UCL have significantly boosted the effectiveness of a therapeutic vaccine designed to control chronic hepatitis B (HBV) infection, after uncovering and thwarting 'the enemy within'.

13 Apr 2022

Reaction Biology's Novel Approach to Oncology Drug Discovery at AACR Showcase

Reaction Biology, an industry-leading provider of drug discovery services, today announced that twelve abstracts highlighting data from the Company's oncology drug discovery services platform will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2022, held April 8-13, 2022, in New Orleans, Louisiana.

From Reaction Biology Corporation 13 Apr 2022

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

Researchers examined the risk of breakthrough COVID-19 infections, hospitalizations, and mortality among COVID-19-vaccinated cancer patients.

13 Apr 2022

PFAS exposure associated with increased risk of developing diabetes in midlife women

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) finds that exposure to per- and polyfluoroalkyl substances (PFAS) - a large and diverse group of industrial chemicals found in many everyday products - is associated with an increased risk of developing diabetes in midlife women.

12 Apr 2022

New analysis finds more cancer diagnosis through emergency routes in the UK

More cancers are being diagnosed through emergency routes in the UK than in comparable high-income countries, according to new analysis by the International Cancer Benchmarking Partnership (ICBP), which is hosted by Cancer Research UK.

12 Apr 2022

Researchers calculate the impact of consuming ultra-processed foods on obesity risk

Based on data for 3,587 adolescents aged 12-19 who took part in the 2011-16 National Health and Nutrition Examination Survey (NHANES) in the United States, researchers at the University of São Paulo (USP) in Brazil have calculated the impact of consuming ultra-processed foods on the risk of obesity.

12 Apr 2022

Dog owners' feeding habits and the impact of FDA hygiene protocols on dog food dish contamination

A survey has recently been conducted by the North Carolina State University, USA, to evaluate the pet food and dish handling habits of pet owners and their impact on bacterial contamination.

12 Apr 2022

Study finds molecular features responsible for the development of metastatic breast cancer

Susana Garcia-Recio, PhD, a research associate in the lab of Charles M. Perou, PhD, at UNC Lineberger Comprehensive Cancer Center, will present findings that identified molecular features responsible for the development and progression of metastatic breast cancer at the 2022 American Association for Cancer Research annual meeting. (Presentation: Abstract LB176/4, Tuesday, April 12, 3:20 p.m. ET, Room 217-219, Ernest N. Morial Convention Center in New Orleans.)

11 Apr 2022

Researchers make progress to develop a drug for treating metabolic syndrome

Metabolic syndrome increases a person's risk for diabetes, heart disease, and stroke, and includes conditions such as obesity, high blood pressure and high blood sugar.

11 Apr 2022

Study explores phytochemical-based antivirals against SARS-CoV-2 infection

A new study depicted plant-based biologically active antiviral agents that are effective against SARS-CoV-2 infection.

11 Apr 2022

Computational network science approach reveals new mechanisms for coronaviruses infections

A group of bat viruses related to SARS-CoV-2 can also infect human cells but uses a different and unknown entryway.

8 Apr 2022

City of Hope's late-breaking clinical trial data to be presented at AACR

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, will present late-breaking and clinical trial findings at this year's American Association for Cancer Research Annual Meeting, which begins today.

8 Apr 2022

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease

A hormone that triggers puberty and controls fertility in humans might be developed as a treatment for non-alcoholic fatty liver disease, according to new Rutgers research.

7 Apr 2022

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

A recent study posted to the medRxiv* preprint server investigated the elements that predicted all-cause mortality among individuals hospitalized due to influenza, respiratory syncytial virus (RSV), or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

7 Apr 2022

Liver News and Research

Study explores role of APOBEC-mediated RNA editing in SARS-CoV-2 fitness

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

UCL researchers boost the effectiveness of therapeutic vaccine for chronic HBV

Reaction Biology's Novel Approach to Oncology Drug Discovery at AACR Showcase

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

PFAS exposure associated with increased risk of developing diabetes in midlife women

New analysis finds more cancer diagnosis through emergency routes in the UK

Researchers calculate the impact of consuming ultra-processed foods on obesity risk

Dog owners' feeding habits and the impact of FDA hygiene protocols on dog food dish contamination

Study finds molecular features responsible for the development of metastatic breast cancer

Researchers make progress to develop a drug for treating metabolic syndrome

Study explores phytochemical-based antivirals against SARS-CoV-2 infection

Computational network science approach reveals new mechanisms for coronaviruses infections

City of Hope's late-breaking clinical trial data to be presented at AACR

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

New platform for studying how the immune system responds to hepatitis C

Study explores incidence of cardiac impairment a year after SARS-CoV-2 infection

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

How comorbidities impact antibody response to COVID vaccination

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News